BioVenture VoiCes Episode 31: Polaris Partners' Amy Schulman
- Dec 29, 2025
- 1 min read
She describes her career beginnings as a lawyer, which led to general counsel and business unit head roles at Pfizer, and then joining the VC world at Polaris Partners (at Bob Langer's urging). She discusses the firm's investment philosophy, the nuances behind how companies choose lead assets, and the cycles biotech has been through over the last ten years. Plus, other roles she currently serves, including being the chair of Alnylam.
Chapters
Intro and early life – 0:43
Law firm work – 11:01
Pfizer Celebrex – 16:38
Pfizer General Counsel – 22:24
Polaris 33:21
The last 10 years – 41:35
Polaris’ investment strategy – 48:57
Investing in entrepreneurs – 54:20
Other roles – 58:00
.png){kind=logo}